Protocol for the Smoking, Nicotine and Pregnancy (SNAP) trial: Double-blind, placebo-randomised, controlled trial of nicotine replacement therapy in pregnancy

BMC Health Services Research

Volumn 7, Issue , 2007, Pages

  Coleman, Tim ^a   Thornton, Jim ^a   Britton, John ^a   Lewis, Sarah ^a   Watts, Kim ^a   Coughtrie, Michael W H ^b   Mannion, Clare ^c   Marlow, Neil ^a   Godfrey, Christine ^d  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c Central Cheshire PCT ^*  (United Kingdom)

^d UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; NICOTINE PATCH; PLACEBO; NICOTINE;

ARTICLE; BEHAVIOR THERAPY; CLINICAL RESEARCH; CLINICAL TRIAL; COGNITIVE DEVELOPMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEALTH PROMOTION; HUMAN; HUMAN EXPERIMENT; MATERNAL BEHAVIOR; NEWBORN CARE; NICOTINE REPLACEMENT THERAPY; PATIENT EDUCATION; PERINATAL DEVELOPMENT; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; SMOKING; SMOKING CESSATION; ADOLESCENT; ADULT; COST BENEFIT ANALYSIS; COUNSELING; FOLLOW UP; PREGNANCY OUTCOME; PRENATAL CARE; PROCEDURES; PSYCHOLOGY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAFETY; SELF DISCLOSURE; TREATMENT OUTCOME; UNITED KINGDOM;

ADOLESCENT; ADULT; COST-BENEFIT ANALYSIS; COUNSELING; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; NICOTINE; PREGNANCY; PREGNANCY OUTCOME; PRENATAL CARE; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SAFETY; SELF DISCLOSURE; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 33846588451     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-7-2     Document Type: Article

References (35)

1. Owen L, Penn G: Smoking and pregnancy: A survey of knowledge attitudes and behaviour, 1992-1999. London, Health Development Agency; 1999.
2. Smoking and the young: A report of a working party of the Royal College of Physicians. London, RCP; 1992.
3. Charlton A: Children and smoking: the family circle. British Medical Bulletin 1996, 52:90-107.
4. Batstra L, Hadders-Algra M, Neeleman J: Effect of antenatal exposure to maternal smoking on behavioural problems and academic achievement in childhood: prospective evidence from a Dutch birth cohort. Early Human Development 2003, 75:21-33.
5. Silagy C: Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews 2000.
6. Britton J, Jarvis MJ: Bupropion: a new treatment for smokers. BMJ 2000, 321:65-66.
7. Lumley J: Interventions for promoting smoking cessation during pregnancy. Cochrane Database of Systematic Reviews 2002.
8. West R, McNeill A, Raw M: Smoking cessation guidelines for health professionals: an update. Thorax 2000, 55:987-999.
9. Dempsey DA, Benowitz NL: Risks and benefits of nicotine to aid smoking cessation in pregnancy. Drug Saf 2001, 24:277-322.
10. National Institute for Clinical Excellence: Guidance on the use of nicotine replacement therapy (NRT) and bupropion for smoking cessation. In Technology Appraisal Guidance No. 39 London, National Institute for Clinical Excellence; 2002.
11. Fiore MC, Hatsukami DK, Baker TB: Effective tobacco dependence treatment. JAMA 2002, 288:1768-1771.
12. Wisborg K, Henriksen TB, Jespersen LB, Secher NJ: Nicotine patches for pregnant smokers: a randomized controlled study. Obstetrics & Gynecology 2000, 96:967-971.
13. Kapur B, Hackman R, Selby P, Klein J, Koren G: Randomized, double-blind, placebo-controlled trial of nicotine replacement therapy in pregnancy. Current Therapeutic Research, Clinical & Experimental 2001, 62:274-278.
14. Hegaard HK, KjAErgaard H, MOller LF, Wachmann H, Ottesen B: Multimodal intervention raises smoking cessation rate during pregnancy. Acta Obstetricia et Gynecologica Scandinavica 2003, 82:813-819.
15. Dempsey D, Jacob P III, Benowitz NL: Accelerated metabolism of nicotine and cotinine in pregnant smokers. Journal of Pharmacology & Experimental Therapeutics 2002, 301:594-598.
16. Tobacco Advisory Group of the Royal College of Physicians: Nicotine addiction in Britain London: Royal College of Physicians of London; 2000.
17. SRNT Subcommittee on Biochemical Verification: Biochemical verification of tobacco use and cessation. Nicotine & Tobacco Research 2002, 4:149-159.
18. Anonymous: Improving local access to smoking cessation therapies by using patient group directions. 2004 [http://www.doh.gov.uk/tobacco/ cessation.htm]. London, Pharmacy Health
19. Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE: Measures of abstinence in clinical trials: issues and recommendations. Nicotine & Tobacco Research 2003, 5:13-25.
20. Kind P, Dolan P, Gudex C, Williams A: Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ 1998, 316:736-741.
21. Thomas MG: Frequent wheeze at follow up of very preterm infants: which factors are predictive? Archives of Disease in Childhood: Fetal & Neonatal Edition 2003, 88:F329-F332.
22. Johnson S, Marlow N, Wolke D, Davidson L, Marston L, O'Hare A, Peacock JL, Schulte J: Validation of a parent report measure of cognitive development for very preterm infants. Developmental Medicine and Child Neurology 2004, 46:389-397.
23. Johnson AH, Peacock JL, Greenough A, Marlow N, Limb ES, Marston L, Calvert SA: High-frequency oscillatory ventilation for the prevention of chronic lung disease of prematurity. New England Journal of Medicine 2002, 347:633-642.
24. McColl E, Jacoby A, Thomas L, Soutter J, Bamford C, Steen N, Thomas R, Harvey E, Garratt A, Bond J: Design and use of questionnaires: a review of best practice applicable to surveys of health service staff and patients. Health Technology Assessment (Winchester, England) 2001, 5:1-256.
25. Neonatal Perinatal Epidemiology Unit and Oxford Health Authority: . Report of two working groups. Disability and perinatal care: measurement of health status at two years. Oxford 1995.
26. Jones HP, Guildea ZE, Stewart JH, Cartlidge PH: The Health Status Questionnaire: achieving concordance with published disability criteria. Archives of Disease in Childhood 2002, 86:15-20.
27. Marlow N: Pulmonary outcomes for the extremely preterm infant. Biology of the Neonate 2000, 78:239-240.
28. Coleman T, Stevenson K, Wilson A: A new method for describing smokers' consulting behaviours which indicate their motivation to stop smoking: an exploration of validity and reliability. Fam Pract 2002, 19:154-160.
29. Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J: Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. British Journal of Addiction 1989, 84:791-799.
30. Health Development Agency Expert Panel: Standard for training in smoking cessation treatments. London, Health Development Agency; 2003.
31. Lancaster T, Stead LF: Individual behavioural counselling for smoking cessation (Cochrane Review). In The Cochrane Library Issue 4 Chichester, UK: John Wiley & Sons, Ltd; 2003.
32. Windsor R: Smoking cessation or reduction in pregnancy treatment methods: a meta-evaluation of the impact of dissemination. American Journal of the Medical Sciences 2003, 326:216-222.
33. Woolacott NF, Jones L, Forbes CA, Mather LC, Sowden AJ, Song FJ, Raftery JP, Aveyard PN, Hyde CJ, Barton PM: The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation. Health Technology Assessment 2002, 6:.
34. Windsor RA, Lowe JB, Perkins LL, Smith-Yoder D, Artz L, Crawford M, Amburgy K, Boyd NR Jr: Health education for pregnant smokers: its behavioral impact and cost benefit. American Journal of Public Health 1993, 83:201-206.
35. Orme ME, Hogue SL, Kennedy LM, Paine AC, Godfrey C: Development of the health and economic consequences of smoking interactive model. Tobacco Control 2001, 10:55-61.